BARD MAX-CORE Disposable Core Biopsy Instrument recalled over fire hazard
- Recall date
- September 22, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Bard Peripheral Vascular Inc recalls BARD MAX-CORE Disposable Core Biopsy Instrument, Product Codes - MC1410, 14 g x 10 cm; MC1616, 16 g x 16 cm; MC1816, 18…
- Recall number
- Z-0044-2018
- FDA classification
- Class II
- Brand / firm
- Bard Peripheral Vascular Inc
- Sold / distributed
- US, Australia, Canada, Europe, Middle East, Africa, Latin America, Asia Pacific
Why it was recalled
During the review of May 2017 complaint data, a significant increase in MAX-CORE Disposable Core Biopsy Instrument complaints was observed for Failure to Prime, Failure to Fire, Failure to Obtain Sample, and Self-Activation.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
BARD MAX-CORE Disposable Core Biopsy Instrument, Product Codes - MC1410, 14 g x 10 cm; MC1616, 16 g x 16 cm; MC1816, 18 g x 16 cm; MC1820, 18 g x 20 cm; MC1825, 18 g x 25 cm. The core needle biopsy device is intended for use in obtaining biopsies from soft tissues.
Get recall alerts
Free email alert whenever Bard Peripheral Vascular Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Bard Peripheral Vascular Inc